High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration

Background/Aim. Recent data imply the significance of certain cytokines in the appearance and development of prostate cancer (PC), as well as their association with pathohistological and/or clinical characteristics of PC. The aim of this study was to examine the relationship between the IL-10 concen...

Full description

Saved in:
Bibliographic Details
Main Authors: Jovanović Dejan, Bančević Vladimir, Jovanović Vanja, Šupić Gordana, Abazovic Dzihan, Stanojevic Ivan, Vojvodić Danilo
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900117J.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212649235644416
author Jovanović Dejan
Bančević Vladimir
Jovanović Vanja
Šupić Gordana
Abazovic Dzihan
Stanojevic Ivan
Vojvodić Danilo
author_facet Jovanović Dejan
Bančević Vladimir
Jovanović Vanja
Šupić Gordana
Abazovic Dzihan
Stanojevic Ivan
Vojvodić Danilo
author_sort Jovanović Dejan
collection DOAJ
description Background/Aim. Recent data imply the significance of certain cytokines in the appearance and development of prostate cancer (PC), as well as their association with pathohistological and/or clinical characteristics of PC. The aim of this study was to examine the relationship between the IL-10 concentration with histopathological and clinical characteristics of PC patients. Methods. IL-10 concentration was determined in serum, urine and prostate massage secret (pms) samples of 88 CP patients (initially and after therapy), 20 benign prostatic hyperplasia (BPH) patients and 15 healthy controls. Results. Compared to BPH and control groups, PC patients had the highest average serum IL-10 concentration. Interestingly, BPH patients demonstrated the highest concentration of IL-6 in urine and pms samples. Also, patients with G3 gradus and with the highest Gleason score (4 + 4) demonstrated the highest IL-10 serum level. PC patients without any histopathological sign of tumor invasion had a significantly increased serum IL-10, either before or after the therapy, compared to the patient group with evident invasion of tumor cells. The therapy induced different IL-10 profile in serum and urine samples. After the therapy, there was a clear significant IL-10 increase in serum of patients with unfavorable Gleason score (4 + 4), with present infiltration of tumor cells in peritumoral tissue (lymphatic, vascular and combined) and in patients with high tumor volume. Conclusion. PC patients without any histopathological signs of tumor invasion before the therapy have significantly increased serum IL-10 concentration compared to those with the signs of tumor invasion. There is a clear dissociation of IL-10 values between a serum sample and local, urine and pms samples from a particular patient. After the therapy, high IL-10 serum concentration is present only in patients with high Gleason score, pre-sent infiltration of peritumoral tissue and high tumor volume.
format Article
id doaj-art-89f2581da89c48f8bcebb2a60f302d06
institution OA Journals
issn 0042-8450
2406-0720
language English
publishDate 2021-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-89f2581da89c48f8bcebb2a60f302d062025-08-20T02:09:18ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202021-01-0178665165810.2298/VSP190820117J0042-84501900117JHigh level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltrationJovanović Dejan0https://orcid.org/0000-0002-0424-0656Bančević Vladimir1https://orcid.org/0000-0003-0406-9008Jovanović Vanja2Šupić Gordana3https://orcid.org/0000-0003-0350-4733Abazovic Dzihan4Stanojevic Ivan5Vojvodić Danilo6https://orcid.org/0000-0001-9308-3076Military Medical Academy, Institute of Radiology, Belgrade, SerbiaMilitary Medical Academy, Clinic for Urology, Belgrade, Serbia + University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia Health Center New Belgrade - General Practice, Belgrade, SerbiaUniversity of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia + Military Medical Academy, Institute for Medical Research, Belgrade, SerbiaEmergency Medical Center of Montenegro, Podgorica, MontenegroUniversity of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia + Military Medical Academy, Institute for Medical Research, Belgrade, SerbiaUniversity of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia + Military Medical Academy, Institute for Medical Research, Belgrade, SerbiaBackground/Aim. Recent data imply the significance of certain cytokines in the appearance and development of prostate cancer (PC), as well as their association with pathohistological and/or clinical characteristics of PC. The aim of this study was to examine the relationship between the IL-10 concentration with histopathological and clinical characteristics of PC patients. Methods. IL-10 concentration was determined in serum, urine and prostate massage secret (pms) samples of 88 CP patients (initially and after therapy), 20 benign prostatic hyperplasia (BPH) patients and 15 healthy controls. Results. Compared to BPH and control groups, PC patients had the highest average serum IL-10 concentration. Interestingly, BPH patients demonstrated the highest concentration of IL-6 in urine and pms samples. Also, patients with G3 gradus and with the highest Gleason score (4 + 4) demonstrated the highest IL-10 serum level. PC patients without any histopathological sign of tumor invasion had a significantly increased serum IL-10, either before or after the therapy, compared to the patient group with evident invasion of tumor cells. The therapy induced different IL-10 profile in serum and urine samples. After the therapy, there was a clear significant IL-10 increase in serum of patients with unfavorable Gleason score (4 + 4), with present infiltration of tumor cells in peritumoral tissue (lymphatic, vascular and combined) and in patients with high tumor volume. Conclusion. PC patients without any histopathological signs of tumor invasion before the therapy have significantly increased serum IL-10 concentration compared to those with the signs of tumor invasion. There is a clear dissociation of IL-10 values between a serum sample and local, urine and pms samples from a particular patient. After the therapy, high IL-10 serum concentration is present only in patients with high Gleason score, pre-sent infiltration of peritumoral tissue and high tumor volume.http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900117J.pdfinterleukin-10interleukinsneoplasm gradingprostate neoplasmsprostatic hyperplasia
spellingShingle Jovanović Dejan
Bančević Vladimir
Jovanović Vanja
Šupić Gordana
Abazovic Dzihan
Stanojevic Ivan
Vojvodić Danilo
High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
Vojnosanitetski Pregled
interleukin-10
interleukins
neoplasm grading
prostate neoplasms
prostatic hyperplasia
title High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
title_full High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
title_fullStr High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
title_full_unstemmed High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
title_short High level of interleukin-10 in serum after therapy is characteristic of prostate carcinoma patients with high Gleason score, high tumor volume and present peritumoral infiltration
title_sort high level of interleukin 10 in serum after therapy is characteristic of prostate carcinoma patients with high gleason score high tumor volume and present peritumoral infiltration
topic interleukin-10
interleukins
neoplasm grading
prostate neoplasms
prostatic hyperplasia
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900117J.pdf
work_keys_str_mv AT jovanovicdejan highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT bancevicvladimir highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT jovanovicvanja highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT supicgordana highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT abazovicdzihan highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT stanojevicivan highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration
AT vojvodicdanilo highlevelofinterleukin10inserumaftertherapyischaracteristicofprostatecarcinomapatientswithhighgleasonscorehightumorvolumeandpresentperitumoralinfiltration